Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
Contact Us | Free E-Mail Updates | Journals | Register a colleague
Doctor's Guide Free CME
Congress Resource Centre

   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition

Warning | Privacy


 Recent webcasts/CME - Schizophrenia
    Real World Management of Schizophrenia in the Comorbid Patient

    Webcasts/CME archive

     Recent news - Schizophrenia
      TopAbstracts in Schizophrenia 05/23/2013 - (DGNews)
      TopAbstracts in Schizophrenia 04/25/2013 - (DGNews)
      TopAbstracts in Schizophrenia 04/11/2013 - (DGNews)
      TopAbstracts in Schizophrenia 03/28/2013 - (DGNews)
      Reducing Dose of Antipsychotic Drug May Improve Cognitive Function in Patients With Schizophrenia: Presented at AAGP - (DGDispatch)

      News archive

       Recent cases - Schizophrenia
        Severe Hyperglycemia Induced by Olanzapine was Improved with a Recovery of Insulin Secretion after Switching to Risperidone and Introducing Insulin Therapy
        The Insulin Sparing Effect of Telmisartan in a Case of Type 2 Diabetes Mellitus Associated with Schizophrenia under Treatment of Risperidone
        Graves' Disease Presenting as Paranoid Schizophrenia in a Nigerian Woman: A Case Report
        Schizophrenia-Like Psychosis Following Left Putamen Infarct: A Case Report
        Localisation Using Mini C-Arm Fluoroscopy of Needles Ingested by a Woman with Schizophrenia: A Case Report

        Cases archive

        personal edition > schizophrenia > webcasts/CME

          E-Mail this webcast/CME to a colleague

        news Practical Dosing Strategies in the Treatment of Schizophrenia

        Presented by:The Mount Sinai School of Medicine
        LecturerDelbert Robinson, MD, Christoph U. Correll, MD and John M. Kane, MD
        Approximate duration:2 hrs.
        Summary points:This CME activity interprets clinical evidence regarding the dosage, efficacy, and safety profiles of pharmacotherapeutic agents to treat first-episode schizophrenia; formulates dosing strategies to achieve optimal antipsychotic efficacy with minimal adverse events; and discusses the timeframe associated with the onset of action for antipsychotics.
        Accreditation:The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The Mount Sinai School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits. Expiration date: April 30, 2012.
        Other:Text-only CME.

        Additional Information

        Discussion group:No
        Feedback possible:No
        Minimum connection needed:28.8
        Plugins needed:Acrobat

        Go to webcast/CME

        E-Mail this webcast/CME to a colleague

        Remind me of this

        All contents Copyright (c) 1995-2018 Doctor's Guide Publishing Limited. All rights reserved.